2023 EpiCast Report: Insomnia - Epidemiology Forecast

1
EpiCast Report Insomnia - Epidemiology Forecast
to 2023 www.bigmarketresearch.com
2
Acquired (Autoimmune) Hemolytic Anemia
Report Description
GlobalData epidemiologists forecast that the
total prevalent cases of acute insomnia in the
7MM will increase from 121,799,911 total
prevalent cases in 2013, to 130,482,156 total
prevalent cases in 2023 at an Annual Growth Rate
(AGR) of 0.71. GlobalData epidemiologists
forecast an increase in the total prevalent cases
of chronic insomnia (not fulfilling DSM-IV
criteria) in the 7MM from 62,982,390 total
prevalent cases in 2013, to 67,471,957 total
prevalent cases in 2023 at an AGR of 0.71. The
7MM had an estimated 23,690,040 total prevalent
cases of chronic primary insomnia in 2013 and the
number of total prevalent cases is expected to
increase to 25,378,728 by 2023, at an AGR of
0.71. GlobalData epidemiologists forecast that
the total prevalent cases of chronic secondary
insomnia in the 7MM will increase from 53,697,425
total prevalent cases in 2013, to 57,525,122
total prevalent cases in 2023 at an AGR of
0.71. Read complete report here _at_
http//www.bigmarketresearch.com/epicast-report-i
nsomnia-epidemiology-forecast-to-2023-market
3
Acquired (Autoimmune) Hemolytic Anemia
Report Description
Insomnia is a highly prevalent condition
approximately one third of the general population
presents with some degree of insomnia. GlobalData
epidemiologists used comprehensive
country-specific data from population-based
studies published in peer-reviewed journal
articles to arrive at a meaningful, in-depth
analysis and forecast for the total prevalent
cases of acute insomnia, chronic insomnia (not
fulfilling DSM-IV criteria), chronic primary
insomnia, and chronic secondary insomnia in the
7MM, based on the DSM-IV criteria. For all the
7MM, the total prevalent cases of acute insomnia,
chronic insomnia (not fulfilling DSM-IV
criteria), chronic primary insomnia, and chronic
secondary insomnia were segmented by age and sex,
which facilitates an understanding of the
distribution of the disease within the population
and informs strategies to improve the management
of the disease. Furthermore, the forecast
methodology is consistent across each of the 7MM,
thereby allowing for a meaningful comparison of
the forecast total prevalent cases among each
market. Get enquire about report here _at_
http//www.bigmarketresearch.com/report-enquiry/1
78077
4
Acquired (Autoimmune) Hemolytic Anemia
Table Of Contents

• 1. Introduction
• Catalyst
• Related Reports
• Upcoming Related Reports
• 2. Europe Refining Industry
• Disease Background
• Risk Factors and Comorbidities
• Global Trends
• Forecast Methodology
• Sources Used
• Sources Not Used
• Forecast Assumptions and Methods
• Epidemiological Forecast for Acute Insomnia
  (2013-2023)

5
Acquired (Autoimmune) Hemolytic Anemia
Table Of Contents

• 3. Appendix
• Bibliography
• About the Authors
• Epidemiologists
• Reviewers
• Global Director of Therapy Analysis and
  Epidemiology
• Get complete TOC _at_ http//www.bigmarketresearch.co
  m/epicast-report-insomnia-epidemiology-forecast-to
  -2023-market

6
Acquired (Autoimmune) Hemolytic Anemia
Report Description

• Reasons to buy
• Develop business strategies by understanding the
  trends shaping and driving the global insomnia
  market.
• Quantify patient populations in the global
  insomnia market to improve product design,
  pricing, and launch plans.
• Organize sales and marketing efforts by
  identifying the sex and age groups that present
  the best opportunities for insomnia therapeutics
  in each of the markets covered.

7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/epicast-report-in
somnia-epidemiology-forecast-to-2023-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
help_at_bigmarketresearch.com